Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 457, 532 (29 January 2009) | doi:10.1038/457532b; Published online 28 January 2009
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Postdoctoral Position Studying Immunology
- The University of Chicago
- Chicago, IL
Pharmacology Group Leader
- S*BIO Pte Ltd
- Singapore
Much ado about cognitive enhancement
João Ricardo Oliveira1
- Neuropsychiatry Department and Keizo Asami Laboratory, Federal University of Pernambuco, 50670-901, Recife-PE, Brazil
Henry Greely and colleagues call for answers to several controversial questions regarding the use of drugs by healthy people to boost cognitive performance ('Towards responsible use of cognitive-enhancing drugs by the healthy' Nature 456, 702–705; 2008). The most important scientific and ethical concern they raise is safety, not least because the pressure that leads people to enhance their performance might also be a crucial trigger to mental disorder.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Offering unproven genetic tests to the public is irresponsibleNature Correspondence (04 Dec 2008)
Recall of learned information may rely on taking drug againNature Correspondence (29 Jan 2009)
A medical view of potential adverse effectsNature Correspondence (29 Jan 2009)
Risks and benefits may turn out to be finely balancedNature Correspondence (29 Jan 2009)
Patterns of drug use have varied throughout historyNature Correspondence (29 Jan 2009)
See all 7 matches for Research